Latest papers

New xanthoquinodin-like compounds, JBIR-97, -98 and -99, obtained from marine sponge-derived fungus Tritirachium sp. SpB081112MEf2.

Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population.

Fatal pemetrexed-induced lung injury in patients with advanced mesothelioma: a report of two cases.

CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection.

A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma.

[A case of malignant peritoneal mesothelioma treated effectively with cisplatin and gemcitabine].

Review of carbon nanotubes toxicity and exposure--appraisal of human health risk assessment based on open literature.

WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer.

TS, DHFR and GARFT expression in non-squamous cell carcinoma of NSCLC and malignant pleural mesothelioma patients treated with pemetrexed.

[A case of diffuse peritoneal malignant mesothelioma--intraabdominal administration of cisplatin is useful for diminishing ascites].

A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.

Cytokeratin 19 fragment/carcinoembryonic antigen ratio in pleural effusion is a useful marker for detecting malignant pleural mesothelioma.

[Cardiac tumors: CT and MR imaging features].

Metastatic peritoneal mesothelioma in the setting of recurrent ascites: a case report.

Potency factors for risk assessment at Libby, Montana.

What should a support program for people with lung cancer look like? Differing attitudes of patients and support group facilitators.

Aberrant promoter methylation of WIF-1 and SFRP1, 2, 4 genes in mesothelioma.

Chest pain and ST elevation: not always ST-segment-elevation myocardial infarction.

Targeted proteasome inhibition by Velcade induces apoptosis in human mesothelioma and breast cancer cell lines.

Pro-tumorigenic effects of miR-31 loss in mesothelioma.